| Norvasc Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Norvasc 2.5 mg | tablet | oral | 1.0 each | OTC |
| Norvasc 5 mg | tablet | oral | 1.0 each | OTC |
| Norvasc 10 mg | tablet | oral | 1.0 each | OTC |
Posted by ladyrich007 16 days ago
Are there any meds that are safe? I was taking 10mg norvasc. I started taking 20/25 mg lisinopril. I was doing ok on the norv...
Posted by lms6987 2 months ago
I have been on a generic form of Norvasc (only 2.5 mg) for two months. No swelling that I have noticed but in the past few w...
Posted by maritsa 2 months ago
I have been on Norvasc for about 3 weeks, and just today I saw swelling around my ankles. I am going to talk to my doctor ab...
Pfizer Reaffirms FY08 Outlook; To File 15-20 Regulatory ... - RTT News
The rise in revenues was in spite of the March 2007 loss of US exclusivity of Norvasc, which contributed to a decrease in Norvasc revenues of $667 million. ...
Wed Mar 05 12:30:43 -0500 2008
Pfizer Fourth Quarter Earnings Call - 123Jump.com
Revenues increased 1% to $48.6 billion compared with 2006 despite the loss of US exclusivity in both Norvasc and Zoloft. - Net income of $8.3 billion or ...
Mon Mar 03 10:26:16 -0500 2008
Why MNCs don’t bring blockbuster drugs into India - Hindu Business Line
... Pfizer’s cholesterol drug Lipitor and anti-hypertension drug Norvasc are some original drugs that did not get launched in the Indian market, he said. ...
Wed Feb 27 13:16:55 -0500 2008
amlodipine besylate - The besylate salt of amlodipine, a synthetic, dihydropyridine, calcium channel blocker with antihypertensive and antianginal effects. Amlodipine inhibits the influx of extracellular calcium ions into myocardial and peripheral vascular smooth muscle cells, thereby preventing vascular and myocardial contraction. This results in a dilatation of the main coronary and systemic arteries,decreases myocardial contractility, increases blood flow and oxygen delivery to the myocardial tissue and decreases total peripheral resistance. This agent may also modulate multi-drug response (MDR) activity through inhibition of the p-glycoprotein efflux pump.